FOR IMMEDIATE RELEASE
Winnipeg, Manitoba - May 25th, 2022:
Ekosi Health, a Canadian Indigenous-owned health care provider with expertise in clinical cannabinoid therapy has partnered with Cerebra, a Winnipeg based MedTech start-up revolutionizing sleep disorder diagnosis to advance the science of cannabinoid therapy and sleep. While there is promising preliminary evidence on the positive impact of cannabinoid therapies for sleep improvement, results to date have been mixed and highlighted the need for further research.
In a landmark study currently being carried out by the partners, the impact of clinical cannabinoid therapy is being assessed for individuals with sleep disturbance. In this, believed to be a first study of its kind for the field, Cerebra’s Sleep System and its proprietary Odd Ratio Product (ORP) sleep depth metric are being utilized in the comfort of the individuals’ own homes to objectively evaluate the effectiveness of cannabinoid therapy. Ekosi Health’s Chief Medical Officer, Dr. Shelley Turner states, “We are incredibly excited to be working together with Cerebra to drive toward a better, unbiased understanding of the potential of cannabinoid therapy to improve individuals’ sleep quality and, as a result, their overall health”.